Cresset Discovery

Cresset Discovery

Premier Computational Chemistry CRO
Europe (non-EU)
English
Academic affiliation

Cresset Discovery has a proven track record delivering high impact drug discovery projects. Their expert CADD scientists are the best at what they do and work alongside you from the ground up.  They apply the best in silico techniques and give expert advice and guidance, to accelerate your assets through the pipeline.

Individual
Company

Skills

Ligand-based drug design
Structure-based drug design
Scaffold hopping
Virtual screening
Pharmacophore screening
Protein-protein interaction (PPI)
Shape-based screening
Molecular dynamics
Molecular modelling packages
Fragment growing / linking
DMTA optimization

About

Cresset Discovery is a premier computational chemistry CRO with a proven track record of delivering high impact, small molecule discovery projects. Our expert modelers apply the best in silico techniques to accelerate your assets through the pipeline. Our team of 14 modelers provides CADD support at all stages of pre-clinical drug discovery centering on small molecule design for biological targets. We bring a fresh perspective, years of industry experience, outstanding science and a complete professional service. As your scientific partner, we share a real interest in your research and offer objective opinions about which avenues to pursue to advance your project. We will always select the right technology for your project, based on your project requirements and goals.

Work experience

Computational Chemistry Consultancy

Company:
Cresset Discovery
Duration:
Jan 2002
-
present

Our dedicated team of expert CADD scientists has a combined 260 years of experience. We have one of the largest dedicated in-house team of expert modelers in the industry, who have delivered 400+ projects with many leading pharmaceutical, biotech, agrochemical, flavor and fragrance companies.

Education

No items found.

Publications

Case STUDIES

Discovering a Novel Therapy for Urinary Tract Infections Through Outsourcing In-silico Drug Discovery

Orotomides, a new class of DHODH targeting anti-fungal drugs

Identifying promising inhibitors against epilepsy using virtual screening